• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.02% Nasdaq Up 0.41%

    Protalix BioTherapeutics, Inc. (PLX)

    -NYSE MKT
    1.08 Down 0.08(6.90%) Feb 17, 4:01PM EST
    Prev Close:1.16
    Open:1.09
    Bid:N/A
    Ask:N/A
    1y Target Est:2.60
    Beta:0.792697
    Next Earnings Date:N/A
    Day's Range:0.95 - 1.13
    52wk Range:0.26 - 1.48
    Volume:8,845,045
    Avg Vol (3m):3,868,240
    Market Cap:153.99M
    P/E (ttm):2.33
    EPS (ttm):0.46
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PLX

    Comparison

    Symbol% ChgMkt Cap
    PLXDown 6.90%153.99M
    1 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.38
    Quarterly EPS Est (Dec-16) :-0.11
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-0.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in Israel and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback